[Abstract luminous DNA molecule. Genetic and gene manipulation concept. Cut of replacing part of a DNA molecule. Medicine. Innovative in science. Medical science and biotechnology.]
ipopba/iStock via Getty Images
Biotech company Metagenomi (NASDAQ:MGX [https://seekingalpha.com/symbol/MGX]) is utilizing artificial intelligence chips from Amazon Web Services (AMZN [https://seekingalpha.com/symbol/AMZN]) to enhance its gene-editing technology development, a Reuters report said.
Metagenomi noted that AWS's Inferentia chips are more cost-effective compared to competitors such as Nvidia, the report added.
Metagenomi focuses on creating tools to deliver genetic material into the human body for gene editing to treat diseases.
The stock is down 8.6% today.
MORE ON METAGENOMI
* Seeking Alpha’s Quant Rating on Metagenomi [https://seekingalpha.com/symbol/MGX/ratings/quant-ratings]
* Historical earnings data for Metagenomi [https://seekingalpha.com/symbol/MGX/earnings]
* Financial information for Metagenomi [https://seekingalpha.com/symbol/MGX/income-statement]
Metagenomi to use Amazon's chips for gene-editing tools
Published 2 weeks ago
Oct 22, 2025 at 6:15 PM
Negative
Auto